Insider Transactions in Q2 2021 at Castlight Health, Inc. (CSLT)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2021
|
Seth B. Cohen Director |
SELL
Open market or private sale
|
Direct |
50,000
-19.33%
|
$100,000
$2.6 P/Share
|
|
Jun 29
2021
|
Seth B. Cohen Director |
SELL
Open market or private sale
|
Direct |
40,000
-13.4%
|
$80,000
$2.4 P/Share
|
|
Jun 10
2021
|
Bryan E Roberts Director |
BUY
Grant, award, or other acquisition
|
Direct |
70,707
+14.86%
|
-
|
|
Jun 10
2021
|
Michael L. Eberhard Director |
BUY
Grant, award, or other acquisition
|
Direct |
70,707
+14.24%
|
-
|
|
Jun 10
2021
|
David A Ebersman Director |
BUY
Grant, award, or other acquisition
|
Direct |
70,707
+14.86%
|
-
|
|
Jun 10
2021
|
Ed Park Director |
BUY
Grant, award, or other acquisition
|
Direct |
70,707
+14.86%
|
-
|
|
Jun 10
2021
|
David B Singer Director |
BUY
Grant, award, or other acquisition
|
Direct |
70,707
+14.86%
|
-
|
|
Jun 10
2021
|
Kenny Van Zant Director |
BUY
Grant, award, or other acquisition
|
Direct |
70,707
+9.65%
|
-
|
|
Jun 10
2021
|
Judith K. Verhave Director |
BUY
Grant, award, or other acquisition
|
Direct |
70,707
+16.75%
|
-
|
|
Jun 10
2021
|
Seth B. Cohen Director |
BUY
Grant, award, or other acquisition
|
Direct |
70,707
+19.15%
|
-
|
|
Jun 09
2021
|
Seth B. Cohen Director |
SELL
Open market or private sale
|
Direct |
30,000
-11.62%
|
$60,000
$2.2 P/Share
|
|
Jun 07
2021
|
Seth B. Cohen Director |
SELL
Open market or private sale
|
Direct |
40,000
-13.41%
|
$80,000
$2.05 P/Share
|
|
May 20
2021
|
Seth B. Cohen Director |
SELL
Open market or private sale
|
Direct |
15,807
-5.03%
|
$15,807
$1.74 P/Share
|
|
May 17
2021
|
William Bondurant Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
23,750
-7.81%
|
$23,750
$1.61 P/Share
|
|
May 17
2021
|
M.P. Eric Chan Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
9,885
-8.98%
|
$9,885
$1.61 P/Share
|
|
May 17
2021
|
Maeve O'Meara Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
76,439
-5.02%
|
$76,439
$1.61 P/Share
|
|
May 16
2021
|
William Bondurant Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
61,449
+2.61%
|
-
|
|
May 16
2021
|
M.P. Eric Chan Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,584
+4.09%
|
-
|
|
May 16
2021
|
Maeve O'Meara Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
186,290
+2.09%
|
-
|
|
May 12
2021
|
Michael L. Eberhard Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,500
+4.7%
|
-
|